Storia in 3 fonti

US drugmaker scraps plans for £1bn UK research centre

Merck criticises ‘successive UK governments’ as it cancels King’s Cross development

Raccontata da

telegraph.co.uk

bbc.com

independent.co.uk

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

telegraph.co.ukStai leggendo11 mesi fa

US drugmaker scraps plans for £1bn UK research centre

Merck criticises ‘successive UK governments’ as it cancels King’s Cross development

originale

independent.co.uk11 mesi fa

Pharma giant ditches £1bn London research hub and says UK ‘not competitive’

Merck, known as MSD in Europe, criticised the UK’s business environment despite the government saying it has become ‘the most attractive place to invest in the world’

Leggi questa versione → originale

Timeline cronologica

mercoledì 10 settembre 2025·telegraph.co.uk
US drugmaker scraps plans for £1bn UK research centre
Merck criticises ‘successive UK governments’ as it cancels King’s Cross development
giovedì 11 settembre 2025·bbc.com
Merck scraps £1bn expansion in the UK over lack of state investment
The firm, known as MSD in Europe, said there has been a lack of investment in life sciences.

US drugmaker scraps plans for £1bn UK research centre

Pharma giant ditches £1bn London research hub and says UK ‘not competitive’

Timeline cronologica

US drugmaker scraps plans for £1bn UK research centre

Merck scraps £1bn expansion in the UK over lack of state investment

Merck scraps £1bn expansion in the UK over lack of state investment

Pharma giant ditches £1bn London research hub and says UK ‘not competitive’

AstraZeneca pauses £200m Cambridge expansion amid NHS pricing row